M
GILD icon

Mirova’s Gilead Sciences GILD Stock Holding History

Mirova’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
10,020
-25,801
-72% -$3.4M 0.05% 147
2026
Q1 		$4.99M Buy
35,821
+32,097
+862% +$4.49M 0.2% 117
2025
Q4 		$457K Sell
3,724
-311
-8% -$37.8K 0.07% 81
2025
Q3 		$448K Hold
4,035
– – 0.06% 95
2025
Q2 		$447K Buy
4,035
+1,140
+39% +$121K 0.06% 99
2025
Q1 		$324K Buy
+2,895
New +$299K 0.06% 106
2024
Q4 		– Sell
-40,232
Closed -$3.37M – 130
2024
Q3 		$3.37M Hold
40,232
– – 0.58% 42
2024
Q2 		$2.76M Hold
40,232
– – 0.5% 49
2024
Q1 		$2.95M Buy
+40,232
New +$3.09M 0.52% 43
2023
Q3 		– Sell
-2,168
Closed -$167K – 137
2023
Q2 		$167K Sell
2,168
-3,611
-62% -$288K 0.03% 126
2023
Q1 		$479K Buy
+5,779
New +$479K 0.07% 110
2021
Q4 		– Sell
-4,669
Closed -$326K – 191
2021
Q3 		$326K Buy
4,669
+412
+10% +$28.9K 0.04% 126
2021
Q2 		$293K Hold
4,257
– – 0.04% 126
2021
Q1 		$275K Sell
4,257
-14,462
-77% -$933K 0.03% 124
2020
Q4 		$1.09M Buy
18,719
+3,004
+19% +$181K 0.14% 55
2020
Q3 		$993K Sell
15,715
-28
-0.2% -$1.94K 0.16% 41
2020
Q2 		$1.21M Buy
15,743
+3,265
+26% +$250K 0.28% 36
2020
Q1 		$933K Buy
12,478
+5,196
+71% +$359K 0.35% 30
2019
Q4 		$473K Sell
7,282
-235,015
-97% -$15.3M 0.16% 38
2019
Q3 		$15.4M Sell
242,297
-135,084
-36% -$8.83M 1.89% 16
2019
Q2 		$25.5M Buy
377,381
+374,438
+12,723% +$24.6M 2.25% 14
2019
Q1 		$191K Sell
2,943
-21,927
-88% -$1.46M 0.1% 47
2018
Q4 		$1.56M Buy
+24,870
New +$1.74M 0.71% 23

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirova's GILD Position: Q2 2026 in Review

Mirova reduced its Gilead Sciences (GILD) stake by 72% in Q2 2026, selling an estimated $3.4M and leaving 10,020 shares worth $1.27M. The position accounts for 0.05% of the portfolio, ranked #147.

Mirova first reported a position in GILD in Q4 2018 and has held it in 23 quarters since. The position peaked at $25.5M in Q2 2019. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mirova held 10,020 shares of Gilead Sciences worth $1.27M as of Q2 2026.
  • Mirova sold 25,801 Gilead Sciences shares in Q2 2026, an estimated $3.4M.
  • Gilead Sciences made up 0.05% of Mirova's portfolio in Q2 2026, its #147 holding.
  • Mirova first reported a position in Gilead Sciences in Q4 2018 and has held it in 23 quarters since.
  • Mirova's Gilead Sciences position peaked at $25.5M in Q2 2019.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mirova's 13F filing for Q2 2026, filed 13 Aug 2026.